Abattis Bioceuticals Corp Stock Market Value

ATTBF Stock  USD 0.0001  0.00  0.00%   
Abattis Bioceuticals' market value is the price at which a share of Abattis Bioceuticals trades on a public exchange. It measures the collective expectations of Abattis Bioceuticals Corp investors about its performance. Abattis Bioceuticals is trading at 1.0E-4 as of the 24th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Abattis Bioceuticals Corp and determine expected loss or profit from investing in Abattis Bioceuticals over a given investment horizon. Check out Abattis Bioceuticals Correlation, Abattis Bioceuticals Volatility and Abattis Bioceuticals Alpha and Beta module to complement your research on Abattis Bioceuticals.
Symbol

Please note, there is a significant difference between Abattis Bioceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abattis Bioceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abattis Bioceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Abattis Bioceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Abattis Bioceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Abattis Bioceuticals.
0.00
12/05/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
11/24/2024
0.00
If you would invest  0.00  in Abattis Bioceuticals on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Abattis Bioceuticals Corp or generate 0.0% return on investment in Abattis Bioceuticals over 720 days. Abattis Bioceuticals is related to or competes with Crescita Therapeutics. Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada More

Abattis Bioceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Abattis Bioceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Abattis Bioceuticals Corp upside and downside potential and time the market with a certain degree of confidence.

Abattis Bioceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abattis Bioceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Abattis Bioceuticals' standard deviation. In reality, there are many statistical measures that can use Abattis Bioceuticals historical prices to predict the future Abattis Bioceuticals' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abattis Bioceuticals. Your research has to be compared to or analyzed against Abattis Bioceuticals' peers to derive any actionable benefits. When done correctly, Abattis Bioceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp Backtested Returns

We have found three technical indicators for Abattis Bioceuticals Corp, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Abattis Bioceuticals are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

Abattis Bioceuticals Corp has no correlation between past and present. Overlapping area represents the amount of predictability between Abattis Bioceuticals time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Abattis Bioceuticals Corp price movement. The serial correlation of 0.0 indicates that just 0.0% of current Abattis Bioceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test0.99
Residual Average0.0
Price Variance0.0

Abattis Bioceuticals Corp lagged returns against current returns

Autocorrelation, which is Abattis Bioceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Abattis Bioceuticals' pink sheet expected returns. We can calculate the autocorrelation of Abattis Bioceuticals returns to help us make a trade decision. For example, suppose you find that Abattis Bioceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Abattis Bioceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Abattis Bioceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Abattis Bioceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Abattis Bioceuticals pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Abattis Bioceuticals Lagged Returns

When evaluating Abattis Bioceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Abattis Bioceuticals pink sheet have on its future price. Abattis Bioceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Abattis Bioceuticals autocorrelation shows the relationship between Abattis Bioceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Abattis Bioceuticals Corp.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Abattis Pink Sheet

Abattis Bioceuticals financial ratios help investors to determine whether Abattis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abattis with respect to the benefits of owning Abattis Bioceuticals security.